Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control? (original) (raw)
Related papers
An Update in Incretin-Based Therapy: A Focus on Glucagon-Like Peptide-1 Receptor Agonists
Diabetes Technology & Therapeutics, 2012
Incretin-based therapies: focus on effects beyond glycemic control alone
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2013
Incretin-Based Therapies in Type 2 Diabetes Mellitus
The Journal of Clinical Endocrinology & Metabolism, 2008
Incretin based therapies for type 2 diabetes mellitus
Journal of the Indian Medical Association, 2008
Incretin-based therapies and their future in Type 2 diabetes mellitus
Therapy, 2011
The American Journal of Medicine, 2011
The Incretin Approach for Diabetes Treatment: Modulation of Islet Hormone Release by GLP-1 Agonism
Diabetes, 2004
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Therapeutics and Clinical Risk Management, 2009
Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
Diabetes Care, 2010
The Role of Incretins on Insulin Function and Glucose Homeostasis
Endocrinology, 2021
The incretin system and its role in type 2 diabetes mellitus
Molecular and Cellular Endocrinology, 2009
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
Diabetes Care, 2013
An Overview of Incretin-Based Therapies: Pharmacology and Future Perspectives
Bulletin of Pharmaceutical Sciences. Assiut
Incretins: Beyond type 2 diabetes
Diabetes, Obesity and Metabolism
Incretin-based therapies in the treatment of type 2 diabetes — More than meets the eye?
European Journal of Internal Medicine, 2013
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
Diabetes Care, 2013
Incretins: their physiology and application in the treatment of diabetes mellitus
Diabetes/Metabolism Research and Reviews, 2013
Next Step in Incretin-Based Therapy: From Single to Dual Agonism
EMJ Diabetes
Review Article Advances in pharmacotherapy of Type-2 diabetes (Part-2: The incretin mimetics)
Sudan medical journal
Incretin-based therapies: can we achieve glycemic control and cardioprotection?
Journal of Endocrinology, 2013
Drug Safety, 2014
Incretin System: Recent Advances in Glucagon Like Peptide-1 and Dipeptidyl Peptidase-4 Inhibitors
Journal of Patan Academy of Health Sciences, 2015
Diabetes care, 2009
Diabetes & Metabolism, 2013
Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
Diabetes Care, 2011
Therapy in the Early Stage: Incretins
Diabetes Care, 2011
Diabetes/Metabolism Research and Reviews, 2016
Diabetes, 2008
Mayo Clinic Proceedings, 2010
Diabetes, 2012